European Companies Search Engine

Quick Search Power Search
Tips & Tricks
Our help pages Using the Quick Search and Power Search Overview explain how to use our search engine.

Roche Deutschland Holding GmbH, Grenzach-Wyhlen, Germany

Watch

If you put a company on your watch list, we'll notify you on your email address when there are new publications regarding this company.

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Dossier

The dossier is a printable PDF file, summarizing information and publications for this company. The creation of dossiers is included in your subscription. After the creation of the dossier is completed, it will be sent to your email address .

Add to dossier (if available):

This feature is only available to our premium service subscribers.

Learn more about the North Data Premium Service

Name

Roche Deutschland Holding GmbH

Register

Ut
District Court of Freiburg HRB 412761

Address

Emil-Barell-Str. 1, 79639 Grenzach-Wyhlen, Germany

Corporate purpose

Acquisition, maintenance, management and management of companies in the pharmaceutical, chemical, diagnostic and related industries, as well as the supply of management, service and services to and advising companies.

Financials

Revenue Employees

Revenue

For this company, Revenue numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

Employees

For this company, Employees numbers are only available to our premium service subscribers.

Learn more about the North Data Premium Service

History

Network

Loading network
CSV export

Investigative Journalism

Uncover International Corporate Connections with our Free Investigative-Account

Publications

20 Feb 2024
Annual report for the year ending 31/12/2022 · Balance sheet for 31/12/2022 · Earnings statement for 31/12/2022
22 Jan 2024
Managing Director: Marc Eduard Bächli, Clemens Schmid, Hans Ulrich Winkel
22 Jan 2024
Befreiender Konzernabschluss zum Geschäftsjahr vom 01.01.2022 bis zum 31.12.2022
10 Jan 2024
Managing Director: Claudia Fleischer
2 Aug 2023
List of board members
23 May 2023
Managing Director: Daniela N. Kahlert · No longer Managing Director: Christian Paetzke
24 Apr 2023
Aufsichtsrat
12 Jan 2023
Managing Director: Claudia Fleischer · No longer Managing Director: Claus Robert Haberda
20 Oct 2022
Annual report for the year ending 31/12/2021 · Balance sheet for 31/12/2021 · Earnings statement for 31/12/2021
12 Oct 2022
Befreiender Konzernabschluss zum Geschäftsjahr vom 01.01.2021 bis zum 31.12.2021
27 Sept 2022
List of board members
14 Sept 2022
Aufsichtsrat
11 Aug 2022 via TIB MOLBIOL Syntheselabor GmbH
Control, Control: TIB MOLBIOL Syntheselabor GmbH
20 Jun 2022
Managing Director: Clemens Schmid · No longer Managing Director: Thomas A. Schmitz
13 Apr 2022 via TIB Molbiol SL
Partner: TIB Molbiol SL
26 Oct 2021
Befreiender Konzernabschluss gem. § 292 HGB zum Geschäftsjahr vom 01.01.2020 bis zum 31.12.2020
6 Oct 2021
Annual report for the year ending 31/12/2020 · Balance sheet for 31/12/2020 · Earnings statement for 31/12/2020
15 Sept 2021
List of board members
12 May 2021
Original document: “Liste der Gesellschafter“
12 Apr 2021
List of board members
19 Feb 2021
List of board members
20 Oct 2020
Befreiender Konzernabschluss gem. § 292 HGB zum Geschäftsjahr vom 01.01.2019 bis zum 31.12.2019
14 Sept 2020
List of board members
4 Sept 2020
Annual report for the year ending 31/12/2019 · Balance sheet for 31/12/2019 · Earnings statement for 31/12/2019
10 Aug 2020
Managing Director: Marc Bächli · Officer: Thomas Kasperzak · No longer Managing Director: Claudia Böckstiegel
26 Feb 2020
Managing Director: Claus Robert Haberda · No longer Managing Director: Ursula B. E. Redeker
6 Feb 2020
List of board members
2 Oct 2019
Annual report for the year ending 31/12/2018 · Balance sheet for 31/12/2018
5 Sept 2019
Befreiender Konzernabschluss gem. § 292 HGB zum Geschäftsjahr vom 01.01.2018 bis zum 31.12.2018
19 Jun 2019
Managing Director: Thomas A. Schmitz · No longer Managing Director: Edgar Vieth
2 Apr 2019
List of board members
14 Feb 2019
List of board members
9 Nov 2018
Annual report for the year ending 31/12/2017 · Balance sheet for 31/12/2017 · Earnings statement for 31/12/2017
29 May 2018
List of board members
15 May 2018
Befreiender Konzernabschluss gem. § 292 HGB zum Geschäftsjahr vom 01.01.2017 bis zum 31.12.2017
22 Jan 2018
Managing Director: Christian Paetzke · No longer Managing Director: Thomas Schinecker
19 Sept 2017
Annual report for the year ending 31/12/2016 · Balance sheet for 31/12/2016 · Earnings statement for 31/12/2016
6 Jun 2017
Befreiender Konzernabschluss gem. § 292 HGB zum Geschäftsjahr vom 01.01.2016 bis zum 31.12.2016
15 Nov 2016
Managing Director: Thomas Schinecker
11 Aug 2016
Annual report for the year ending 31/12/2015 · Balance sheet for 31/12/2015 · Earnings statement for 31/12/2015
5 Apr 2016
Befreiender Konzernabschluss gem. § 292 HGB zum Geschäftsjahr vom 01.01.2015 bis zum 31.12.2015
4 Mar 2016
Managing Director: Claudia Böckstiegel · No longer Managing Director: Claus-Jörg Rütsch
3 Aug 2015
Annual report for the year ending 31/12/2014 · Balance sheet for 31/12/2014 · Earnings statement for 31/12/2014
29 Jul 2015
Befreiender Konzernabschluss gem. § 292 HGB zum Geschäftsjahr vom 01.01.2014 bis zum 31.12.2014
29 Jan 2015
Befreiender Konzernabschluss zum 31.Dezember 2013 gemäß § 292 HGB
7 Oct 2014
Annual report for the year ending 31/12/2013 · Balance sheet for 31/12/2013 · Earnings statement for 31/12/2013
6 Feb 2014
Befreiender Konzernabschluss zum 31. Dezember 2012 gemäß § 292 HGB
28 Jan 2014
Managing Director: Ursula B. E. Redeker · No longer Managing Director (1)
6 Dec 2013 via Ascur Versicherungsvermittlungs GmbH, also 03/12/2013
Control, Control: Ascur Versicherungsvermittlungs GmbH
6 Dec 2013 via NEXUS SWISSLAB GmbH, also 05/12/2013, 26/10/2009, 22/10/2009
Control, Control: Swisslab GmbH
2 Dec 2013 via ROCHE PHARMA AG, also 27/11/2013
Control, Control: ROCHE PHARMA AG
2 Dec 2013
List of board members
27 Nov 2013 via Verum Diagnostica GmbH, also 09/01/2013
Control, Control: Verum Diagnostica GmbH
8 Jul 2013
Capital: €6,000,000 · Share­holder agreement · Proxy · Corporate Purpose
1 Jul 2013
Annual report for the year ending 31/12/2012 · Balance sheet for 31/12/2012 · Earnings statement for 31/12/2012
26 Jun 2013
Original document: “Gesellschaftsvertrag / Satzung / Statut“
7 Aug 2012 via Roche Holding AG Basel, also 18/11/2011
Shareholder: Roche Holding AG Basel
26 Jul 2012
Annual report for the year ending 31/12/2011 · Balance sheet for 31/12/2011 · Earnings statement for 31/12/2011
22 Aug 2011
Annual report for the year ending 31/12/2010 · Balance sheet for 31/12/2010 · Earnings statement for 31/12/2010
20 Aug 2010 via Roche Holding Ltd., also 11/11/2009, 03/12/2008
Shareholder: Roche Holding Ltd
6 Aug 2010
Annual report for the year ending 31/12/2009 · Balance sheet for 31/12/2009 · Earnings statement for 31/12/2009
22 Mar 2010
Managing Director: Edgar Vieth · No longer Managing Director (1)
14 Oct 2009
Annual report for the year ending 31/12/2008 · Balance sheet for 30/12/2004 · Earnings statement for 31/12/2008
3 Aug 2009 via Roche Innovatis AG
Control, Control: Roche Innovatis AG
14 Apr 2009
Address
29 Oct 2008
Annual report for the year ending 31/12/2007 · Balance sheet for 31/12/2007 · Earnings statement for 31/12/2007 · Shareholdings (10 companies)
4 Feb 2008
Managing Director (1) · No longer Managing Director (1)
14 Dec 2007
Annual report for the year ending 31/12/2006 · Balance sheet for 31/12/2006 · Earnings statement for 31/12/2006 · Shareholdings (10 companies)
14 May 2007
Officer: Dagmar Baake
19 Sept 2006
No longer Managing Director: Dr. Schlingensief, Karl-Hermann, Pharmacist, Grenzach-Whylen
16 Jun 2006
Managing Director: Hagen Pfundner
12 Jun 2006
Reg­is­tra­tion · Officer: Thomas Kasperzak · Managing Director (4) · Capital: 10M DEM · Seat: Grenzach-Wyhlen, Germany · Legal form: GmbH · Name: Roche Deutschland Holding GmbH · Corporate Purpose
13 Oct 2005 via Roche Diagnostics GmbH
Reg­is­tra­tion · MD (8) · PPA (44) · Control: Roche Deutschland Holding GmbH · Control: Roche Deutschland Holding GmbH · Capital: €94.6M · Seat: Mannheim, Germany · Legal form: GmbH …

The data on this page is generated by a fully automated algorithm. It may have errors, and is provided on an "as is" basis with no guarantees of completeness, accuracy, usefulness or timeliness.

Creative Commons License The visualizations for "Roche Deutschland Holding GmbH, Grenzach-Wyhlen, Germany" are provided by North Data and may be reused under the terms of the Creative Commons CC-BY license.

Printing is only available to North Data premium service subscribers.
Close